FDA set to open com­ments on AI use in phar­ma man­u­fac­tur­ing

The FDA wants to know what peo­ple think about the use of AI in the phar­ma man­u­fac­tur­ing space.

Ac­cord­ing to a pub­lic in­spec­tion

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.